← Back to Clinical Trials
Recruiting NCT06398509

NCT06398509 A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06398509
Status Recruiting
Phase —
Sponsor University of California, San Francisco
Condition Obesity, Childhood
Study Type INTERVENTIONAL
Enrollment 576 participants
Start Date 2024-05-13
Primary Completion 2029-06-01

Eligibility & Interventions

Sex All sexes
Min Age 7 Days
Max Age 2 Months
Study Type INTERVENTIONAL
Interventions
ControlFuturos Fuertes 2.0

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 576 participants in total. It began in 2024-05-13 with a primary completion date of 2029-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to evaluate the impact of a primary care based intervention to promote optimal feeding, screen time and sleep practices among low-income Latino infants and toddlers. Infants and caregivers will receive brief health education and coaching sessions from health educators at primary care visits in the first two years of life as well as two text messages per week with health information and tips. Half of the participants will receive the Futuros Fuertes 2.0 intervention that includes health coaching and education on infant feeding, screen time and sleep (intervention group). The other half will receive health coaching and education on safety, home management of childhood illnesses, and promotion of language development (control group). We will look at the impact of the Futuros Fuertes 2.0 intervention on child BMI and various health behaviors.

Eligibility Criteria

Inclusion Criteria: * Parent/caregiver self identifies as Latino * Parent/caregiver speaks Spanish or English * Parent/caregiver intends to receive primary care for infant at participating clinic * Infant gestational age of 37 weeks or greater * Infant birthweight of 2600 grams or greater * For multiples (twins, triplets), one sibling will be chosen at random to participate Exclusion Criteria: -Infant has a serious medical condition that affects feeding or growth

Contact & Investigator

Central Contact

Amy Beck, MD, MPH

✉ amy.beck@ucsf.edu

📞 415-476-3368

Principal Investigator

Amy Beck, MD, MPH

PRINCIPAL INVESTIGATOR

University of California, San Francisco

Frequently Asked Questions

Who can join the NCT06398509 clinical trial?

This trial is open to participants of all sexes, aged 7 Days or older, up to 2 Months, studying Obesity, Childhood. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06398509 currently recruiting?

Yes, NCT06398509 is actively recruiting participants. Contact the research team at amy.beck@ucsf.edu for enrollment information.

Where is the NCT06398509 trial being conducted?

This trial is being conducted at San Francisco, United States, Sunnyvale, United States.

Who is sponsoring the NCT06398509 clinical trial?

NCT06398509 is sponsored by University of California, San Francisco. The principal investigator is Amy Beck, MD, MPH at University of California, San Francisco. The trial plans to enroll 576 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology